MIRAPHARM 22

Dosage form: capsule
Ingredients: PANAX QUINQUEFOLIUS WHOLE 0.06g
Labeler: MIRAPHARM., Inc.
NDC code: 61065-2001

Medically reviewed by Drugs.com. Last updated on Aug 12, 2024.

MIRAPHARM 22

Active ingredients

PANAX QUINQUEFOLIUS 20% (or RED GINSENG 20%)

Purpose

Stimulant

Keep out of reach of children.

Uses

To help the treatment of incurable diseases, various cancer, symptoms of atopy as immunomodulator due to immune deficiency.

Warning

If you take any serious medications or medical condition, consult your doctor

Direction

Take 3 capsules a day (immediately after having breakfast and dinner.)

Other Information

Keep product out of direct sunlight, high temperature and humidity.
Store in a cool dry place.
Any items past the expiration date or damaged in transit can be exchanged where you originally purchased the item.

Inactive Ingredient

Calamus

Packaging

MIRAPHARM 22
panax quinquefolius (red ginseng) capsule

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:61065-2001
Route of Administration	ORAL	DEA Schedule

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
PANAX QUINQUEFOLIUS WHOLE (PANAX QUINQUEFOLIUS WHOLE)	PANAX QUINQUEFOLIUS WHOLE	0.06 g

Inactive Ingredients
Ingredient Name	Strength
ACORUS CALAMUS ROOT

Product Characteristics
Color	white	Score	no score
Shape	CAPSULE	Size	200mm
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description
1	NDC:61065-2001-1	1 BOTTLE in 1 BOX
1		90 CAPSULE in 1 BOTTLE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		02/06/2015

Labeler - MIRAPHARM., Inc. (688735063)

Establishment
Name	Address	ID/FEI	Operations
MIRAPHARM., Inc.		688735063	manufacture(61065-2001)

Revised: 08/2019

Document Id: 90aa99ec-2b7c-7f6c-e053-2995a90a009e

Set id: ca9c6847-c2d7-46b6-9efd-d2864fb2b12a

Version: 4

Effective Time: 20190821

MIRAPHARM., Inc.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

MIRAPHARM 22

Further information

See also:

Qulipta

Aimovig

Dupixent

Gemtesa

Ubrelvy

Nurtec ODT

Xeomin

Tazarotene topical

Topiramate

Dysport